vs

Side-by-side financial comparison of Accel Entertainment, Inc. (ACEL) and Ascendis Pharma A/S (ASND). Click either name above to swap in a different company.

Accel Entertainment, Inc. is the larger business by last-quarter revenue ($341.4M vs $267.3M, roughly 1.3× Ascendis Pharma A/S). On growth, Ascendis Pharma A/S posted the faster year-over-year revenue change (42.3% vs 7.5%). Over the past eight quarters, Ascendis Pharma A/S's revenue compounded faster (60.7% CAGR vs 6.4%).

Legendary Entertainment, LLC is an American mass media and film production company based in Burbank, California, founded by Thomas Tull in 2000. The company has often collaborated with the major studios, including Warner Bros. Pictures, Universal Pictures, Sony Pictures and Paramount Pictures, as well as streaming services such as Netflix and Hulu.

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

ACEL vs ASND — Head-to-Head

Bigger by revenue
ACEL
ACEL
1.3× larger
ACEL
$341.4M
$267.3M
ASND
Growing faster (revenue YoY)
ASND
ASND
+34.8% gap
ASND
42.3%
7.5%
ACEL
Faster 2-yr revenue CAGR
ASND
ASND
Annualised
ASND
60.7%
6.4%
ACEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACEL
ACEL
ASND
ASND
Revenue
$341.4M
$267.3M
Net Profit
$16.2M
Gross Margin
90.5%
Operating Margin
8.7%
Net Margin
4.7%
Revenue YoY
7.5%
42.3%
Net Profit YoY
93.3%
EPS (diluted)
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACEL
ACEL
ASND
ASND
Q4 25
$341.4M
$267.3M
Q3 25
$329.7M
$230.7M
Q2 25
$335.9M
$170.7M
Q1 25
$323.9M
$109.0M
Q4 24
$317.5M
$187.8M
Q3 24
$302.2M
$62.5M
Q2 24
$309.4M
$38.9M
Q1 24
$301.8M
$103.6M
Net Profit
ACEL
ACEL
ASND
ASND
Q4 25
$16.2M
Q3 25
$13.4M
$-65.9M
Q2 25
$7.3M
$-42.0M
Q1 25
$14.6M
$-102.2M
Q4 24
$8.4M
Q3 24
$4.9M
$-107.1M
Q2 24
$14.6M
$-118.1M
Q1 24
$7.4M
$-141.5M
Gross Margin
ACEL
ACEL
ASND
ASND
Q4 25
90.5%
Q3 25
89.5%
Q2 25
80.1%
Q1 25
82.6%
Q4 24
91.9%
Q3 24
80.6%
Q2 24
68.2%
Q1 24
92.1%
Operating Margin
ACEL
ACEL
ASND
ASND
Q4 25
8.7%
Q3 25
7.7%
5.1%
Q2 25
8.0%
-33.5%
Q1 25
8.0%
-103.2%
Q4 24
6.5%
Q3 24
7.2%
-167.3%
Q2 24
7.3%
-370.2%
Q1 24
8.5%
-51.2%
Net Margin
ACEL
ACEL
ASND
ASND
Q4 25
4.7%
Q3 25
4.1%
-28.5%
Q2 25
2.2%
-24.6%
Q1 25
4.5%
-93.7%
Q4 24
2.6%
Q3 24
1.6%
-171.5%
Q2 24
4.7%
-303.9%
Q1 24
2.5%
-136.6%
EPS (diluted)
ACEL
ACEL
ASND
ASND
Q4 25
$0.19
Q3 25
$0.16
Q2 25
$0.08
Q1 25
$0.17
Q4 24
$0.09
Q3 24
$0.06
Q2 24
$0.17
Q1 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACEL
ACEL
ASND
ASND
Cash + ST InvestmentsLiquidity on hand
$296.6M
$665.3M
Total DebtLower is stronger
$607.4M
Stockholders' EquityBook value
$269.7M
$-175.8M
Total Assets
$1.1B
$1.4B
Debt / EquityLower = less leverage
2.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACEL
ACEL
ASND
ASND
Q4 25
$296.6M
$665.3M
Q3 25
$290.2M
$582.2M
Q2 25
$264.6M
$533.6M
Q1 25
$271.9M
$559.4M
Q4 24
$281.3M
$604.3M
Q3 24
$265.1M
$675.6M
Q2 24
$254.9M
$279.4M
Q1 24
$253.9M
$345.9M
Total Debt
ACEL
ACEL
ASND
ASND
Q4 25
$607.4M
Q3 25
$595.4M
Q2 25
$595.5M
Q1 25
$580.7M
Q4 24
$595.4M
Q3 24
$554.1M
Q2 24
$565.7M
Q1 24
$539.9M
Stockholders' Equity
ACEL
ACEL
ASND
ASND
Q4 25
$269.7M
$-175.8M
Q3 25
$267.1M
$-188.0M
Q2 25
$260.5M
$-202.6M
Q1 25
$259.1M
$-205.0M
Q4 24
$255.0M
$-114.2M
Q3 24
$206.7M
$-105.1M
Q2 24
$209.1M
$-346.8M
Q1 24
$202.1M
$-257.2M
Total Assets
ACEL
ACEL
ASND
ASND
Q4 25
$1.1B
$1.4B
Q3 25
$1.1B
$1.2B
Q2 25
$1.1B
$1.2B
Q1 25
$1.0B
$1.1B
Q4 24
$1.0B
$1.3B
Q3 24
$950.2M
$1.2B
Q2 24
$950.3M
$819.0M
Q1 24
$919.1M
$866.7M
Debt / Equity
ACEL
ACEL
ASND
ASND
Q4 25
2.25×
Q3 25
2.23×
Q2 25
2.29×
Q1 25
2.24×
Q4 24
2.33×
Q3 24
2.68×
Q2 24
2.71×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACEL
ACEL
ASND
ASND
Operating Cash FlowLast quarter
$31.1M
$58.2M
Free Cash FlowOCF − Capex
$16.0M
FCF MarginFCF / Revenue
4.7%
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
1.92×
TTM Free Cash FlowTrailing 4 quarters
$62.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACEL
ACEL
ASND
ASND
Q4 25
$31.1M
$58.2M
Q3 25
$55.2M
Q2 25
$19.8M
Q1 25
$44.8M
$-15.5M
Q4 24
$13.5M
$-330.7M
Q3 24
$50.1M
Q2 24
$28.9M
Q1 24
$28.8M
$-109.7M
Free Cash Flow
ACEL
ACEL
ASND
ASND
Q4 25
$16.0M
Q3 25
$34.2M
Q2 25
$-6.2M
Q1 25
$18.0M
Q4 24
$2.1M
Q3 24
$33.1M
Q2 24
$11.4M
Q1 24
$8.1M
FCF Margin
ACEL
ACEL
ASND
ASND
Q4 25
4.7%
Q3 25
10.4%
Q2 25
-1.9%
Q1 25
5.6%
Q4 24
0.7%
Q3 24
11.0%
Q2 24
3.7%
Q1 24
2.7%
Capex Intensity
ACEL
ACEL
ASND
ASND
Q4 25
4.4%
Q3 25
6.4%
Q2 25
7.8%
Q1 25
8.3%
Q4 24
3.6%
Q3 24
5.6%
Q2 24
5.7%
Q1 24
6.8%
Cash Conversion
ACEL
ACEL
ASND
ASND
Q4 25
1.92×
Q3 25
4.13×
Q2 25
2.71×
Q1 25
3.06×
Q4 24
1.62×
Q3 24
10.23×
Q2 24
1.98×
Q1 24
3.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACEL
ACEL

Video Gaming$319.1M93%
ATM Fees And Other Revenue$13.5M4%
Amusement$5.3M2%
Manufacturing$3.6M1%

ASND
ASND

Segment breakdown not available.

Related Comparisons